Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis
Kidney International Reports · 2025-09 · 10 (9) · 2977-2990
DOI: 10.1016/j.ekir.2025.06.047 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Kidney International Reports, 2025-09. Verfasst von Ariel Izcovich und 24 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad del Salvador. Buenos Aires, Argentina. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
This study aimed to evaluate the comparative efficacy and safety of various initial treatments for active lupus nephritis (LN) through a systematic review and network meta-analysis (NMA).
Methods
We conducted a comprehensive literature search across multiple databases from inception to February 2025 to identify randomized controlled trials (RCTs) comparing initial treatments for LN. We performed a frequentist random-effects NMA using the restricted maximum likelihood method to estimate heterogeneity. We used the GRADE approach to assess the certainty of evidence.
Results
We included 40 RCTs encompassing 5450 patients and 16 interventions (12 drugs administered alone or in combination). Mycophenolic acid analogs (MPAAs) were selected as the common comparator. The network meta-analysis revealed that voclosporin (VCS) combined with MPAA (risk difference [RD]: 281.38 more/1000, 95% confidence interval [CI]: 146.26 more to 456.42 more; high certainty), belimumab (BEL) combined with MPAA (RD: 145.02 more/1000, 95% CI: 72.73 more to 230.92 more; high certainty), and obinutuzumab (OBI) combined with MPAA (RD: 134.23 more/1000, 95% CI: 30.37 more to 269.68 more; moderate certainty) increased complete renal response (CRR) compared with MPAA alone. Tacrolimus (TAC) combined with MPAA (RD: 113.69 more/1000, 95% CI: 25.23 more to 217.7 more; low certainty) also showed potential benefits but with low certainty evidence.
Conclusion
Combination therapies, particularly VCS, BEL, or OBI with MPAA, provide enhanced outcomes for LN initial treatment. Given the complexity of LN, clinicians should weigh these findings alongside considerations such as drug availability, cost, and individual patient preferences to guide treatment decisions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Facultad de Medicina, Universidad del Salvador. Buenos Aires, Argentina.
- Servicio de Clínica Médica, Hospital Alemán, Buenos Aires, Argentina.
- Universidad Nacional de Río Negro, Argentina.
- Hospital Fernández, Buenos Aires, Argentina.
- Centro Regional de Enfermedades Autoinmunes y Reumáticas, Grupo Oroño, Rosario, Argentina.
- Seccion Reumatologia, Hospital Italiano de Buenos Aires, Argentina.
Zitieren
APA
Izcovich, A., Tortosa, F., Bengolea, A., Pissinis, M. M., Ragusa, M., Fielli, M., Agnoletti, C., Quintana, R., Malvar, A., Scolnik, M., Bonfá, E., Borba, E. F., Monticielo, O. A., Dos Reis-Neto, E. T., Massardo, L., Gómez-Puerta, J. A., Toro-Gutiérrez, C. E., Esquivel-Valerio, J. A., Loyo, H. F., …, & Grupo Latino Americano de Estudio del Lupus (GLADEL) (2025). Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis. Kidney International Reports, 10(9), 2977-2990. https://doi.org/10.1016/j.ekir.2025.06.047
Vancouver
Izcovich A, Tortosa F, Bengolea A, Pissinis MM, Ragusa M, Fielli M, et al. Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis. Kidney International Reports. 2025;10(9):2977-2990. doi:10.1016/j.ekir.2025.06.047
BibTeX
@article{Izcovich2025,
author = {Izcovich, Ariel and Tortosa, Fernando and Bengolea, Agustín and Pissinis, Moira Magdalena and Ragusa, Martín and Fielli, Mariano and Agnoletti, Camila and Quintana, Rosana and Malvar, Ana and Scolnik, Marina and Bonfá, Eloisa and Borba, Eduardo F and Monticielo, Odirlei Andre and Dos Reis-Neto, Edgard Torres and Massardo, Loreto and Gómez-Puerta, José A and Toro-Gutiérrez, Carlos Enrique and Esquivel-Valerio, Jorge A and Loyo, Hilda Fragoso and Mejia-Vilet, Juan Manuel and Alarcón, Graciela S and Ugarte-Gil, Manuel F and Pons-Estel, Bernardo A and Pons-Estel, Guillermo and Grupo Latino Americano de Estudio del Lupus (GLADEL), Grupo Latino Americano de Estudio del Lupus (GLADEL)},
title = {Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis},
journal = {Kidney International Reports},
year = {2025},
volume = {10},
number = {9},
pages = {2977--2990},
doi = {10.1016/j.ekir.2025.06.047}
}
EUVIMED